MC1R and neoplasm: On day 24, six of the seven (85.7%) mice that received the WT T-47d cells had tumors, while only one of the mice that received the MC1R-KD T-47d cells had a tumor (Fig. 3c, d), suggesting that MC1R signaling was critical for imparting tumorigenicity in T-47d cells.